Literature DB >> 33661756

Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study.

Alexandre Karras1,2, Marine Livrozet2,3, Hélène Lazareth4,2, Nicolas Benichou4,2, Jean-Sébastien Hulot2,3, Antoine Fayol2,3, Sophie Chauvet4,2, Anne-Sophie Jannot2,5, Marie-Aude Penet2,6, Jean-Luc Diehl2,7, Anne Godier2,8, Olivier Sanchez2,9, Tristan Mirault2,10, Eric Thervet4,2, Nicolas Pallet2,11.   

Abstract

BACKGROUND AND OBJECTIVES: Kidney involvement is frequent among patients with coronavirus disease 2019 (COVID-19), and occurrence of AKI is associated with higher mortality in this population. The objective of this study was to describe occurrence and significance of proteinuria in this setting. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS : We conducted a single-center retrospective study to describe the characteristic features of proteinuria measured within 48 hours following admission among patients with COVID-19 admitted in a tertiary care hospital in France, and to evaluate its association with initiation of dialysis, intensive care unit admission, and death.
RESULTS: Among 200 patients with available data, urine protein-creatinine ratio at admission was ≥1 g/g for 84 (42%), although kidney function was normal in most patients, with a median serum creatinine of 0.94 mg/dl (interquartile range, 0.75-1.21). Median urine albumin-creatinine ratio was 110 mg/g (interquartile range, 50-410), with a urine albumin-protein ratio <50% in 92% of patients. Urine retinol binding protein concentrations, available for 85 patients, were ≥0.03 mg/mmol in 62% of patients. Urine protein-creatinine ratio ≥1 g/g was associated with initiation of dialysis (odds ratio, 4.87; 95% confidence interval, 2.03 to 13.0; P<0.001), admission to the intensive care unit (odds ratio, 3.55; 95% confidence interval, 1.93 to 6.71; P<0.001), and death (odds ratio, 3.56; 95% confidence interval, 1.90 to 6.54; P<0.001).
CONCLUSIONS: Proteinuria is very frequent among patients admitted for COVID-19 and may precede AKI. Low levels of albuminuria suggest a predominant tubular origin, confirmed by the elevated levels of urine retinol binding protein. Urine protein-creatinine ratio ≥1 g/g at admission is strongly associated with poor kidney and patient outcome.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  COVID-19; acute renal failure; prognosis; proteinuria; proximal tubule; tubular epithelium

Year:  2021        PMID: 33661756      PMCID: PMC8092053          DOI: 10.2215/CJN.09130620

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

1.  Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases.

Authors:  A G Norden; S J Scheinman; M M Deschodt-Lanckman; M Lapsley; J L Nortier; R V Thakker; R J Unwin; O Wrong
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

2.  Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

Authors:  Jan Wysocki; Enrique Lores; Minghao Ye; Maria Jose Soler; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

3.  Postmortem Kidney Pathology Findings in Patients with COVID-19.

Authors:  Dominick Santoriello; Pascale Khairallah; Andrew S Bomback; Katherine Xu; Satoru Kudose; Ibrahim Batal; Jonathan Barasch; Jai Radhakrishnan; Vivette D'Agati; Glen Markowitz
Journal:  J Am Soc Nephrol       Date:  2020-07-29       Impact factor: 10.121

4.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

5.  Nephrotic syndrome associated with hemophagocytic syndrome.

Authors:  O Thaunat; M Delahousse; F Fakhouri; F Martinez; J-L Stephan; L-H Noël; A Karras
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

6.  Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.

Authors:  Hua Su; Ming Yang; Cheng Wan; Li-Xia Yi; Fang Tang; Hong-Yan Zhu; Fan Yi; Hai-Chun Yang; Agnes B Fogo; Xiu Nie; Chun Zhang
Journal:  Kidney Int       Date:  2020-04-09       Impact factor: 10.612

Review 7.  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).

Authors:  John A Kellum; Norbert Lameire
Journal:  Crit Care       Date:  2013-02-04       Impact factor: 9.097

8.  Acute kidney injury in patients hospitalized with COVID-19.

Authors:  Jamie S Hirsch; Jia H Ng; Daniel W Ross; Purva Sharma; Hitesh H Shah; Richard L Barnett; Azzour D Hazzan; Steven Fishbane; Kenar D Jhaveri
Journal:  Kidney Int       Date:  2020-05-16       Impact factor: 10.612

9.  Kidney disease is associated with in-hospital death of patients with COVID-19.

Authors:  Yichun Cheng; Ran Luo; Kun Wang; Meng Zhang; Zhixiang Wang; Lei Dong; Junhua Li; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Kidney Int       Date:  2020-03-20       Impact factor: 10.612

10.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26
View more
  8 in total

1.  Association of AKI-D with Urinary Findings and Baseline eGFR in Hospitalized COVID-19 Patients.

Authors:  Dipal M Patel; Manali Phadke; Feng Dai; Michael Simonov; Neera K Dahl; Ravi Kodali
Journal:  Kidney360       Date:  2021-05-20

Review 2.  Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.

Authors:  Svetlana P Chapoval; Achsah D Keegan
Journal:  Mol Med       Date:  2021-12-27       Impact factor: 6.376

3.  Predictors of mortality in COVID-19 patients at Kinshasa Medical Center and a survival analysis: a retrospective cohort study.

Authors:  Yannick Nlandu; Danny Mafuta; Junior Sakaji; Melinda Brecknell; Yannick Engole; Jessy Abatha; Jean-Robert Nkumu; Aliocha Nkodila; Marie-France Mboliassa; Olivier Tuyinama; Dauphin Bena; Yves Mboloko; Patrick Kobo; Patrick Boloko; Joseph Tshangu; Philippe Azika; Jean-Pierre Kanku; Pally Mafuta; Magloire Atantama; Jean-Michel Mavungu; Rosita Kitenge; Asma Sehli; Karel Van Eckout; Cathy Mukuku; Léo Bergeret; David Benchetritt; Golan Kalifa; Ahmed Rodolphe; Justine Bukabau
Journal:  BMC Infect Dis       Date:  2021-12-20       Impact factor: 3.090

Review 4.  The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.

Authors:  Krzysztof Ratajczyk; Andrzej Konieczny; Adrian Czekaj; Paweł Piotrów; Marek Fiutowski; Kornelia Krakowska; Paweł Kowal; Wojciech Witkiewicz; Karolina Marek-Bukowiec
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

5.  D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak.

Authors:  David M Smadja; Benjamin A Fellous; Guillaume Bonnet; Caroline Hauw-Berlemont; Willy Sutter; Agathe Beauvais; Charles Fauvel; Aurélien Philippe; Orianne Weizman; Delphine Mika; Philippe Juvin; Victor Waldmann; Jean-Luc Diehl; Ariel Cohen; Richard Chocron
Journal:  Front Cardiovasc Med       Date:  2022-09-06

6.  Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19.

Authors:  Manuel J Vogel; Julian Mustroph; Carsten G Jungbauer; Julian Hupf; Stephan T Staudner; Simon B Leininger; Ute Hubauer; Stefan Wallner; Christine Meindl; Frank Hanses; Markus Zimmermann; Lars S Maier
Journal:  J Nephrol       Date:  2021-06-10       Impact factor: 3.902

7.  [Kidney damage in COVID-19].

Authors:  Stéphane Burtey; Marion Sallée
Journal:  Nephrol Ther       Date:  2021-06-23       Impact factor: 0.722

8.  Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19.

Authors:  Meredith C McAdams; Michael Li; Pin Xu; L Parker Gregg; Jiten Patel; Duwayne L Willett; Ferdinand Velasco; Christoph U Lehmann; S Susan Hedayati
Journal:  BMC Nephrol       Date:  2022-02-01       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.